Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and... see more

CSE:COOL - Post Discussion

Core One Labs Inc > Looks Like Many Are Finally Dumping This Losing POS Stock
View:
Post by bullman246 on Aug 17, 2021 5:09pm

Looks Like Many Are Finally Dumping This Losing POS Stock

Down another 12% on heavy volume today. It looks like investors are finally dumping this money losing POS stock, that hasn't advanced in price, since it's inception 10 years ago.

This stock is truly the worst performing stock I've ever seen. All they do is burn through investor money, and then generate more for their hefty salaries by screwing the retail investor with more and more dilution, through reverse splits and PP's. Pathetic!

The Nasdaq would be totally crazy, to grant a Nasdaq listing to any company that has to resort to reverse splits to artificially jack up the stock price to qualify. Furthermore, what is the sales and revenue of this company? Does anyone know? I suspect not. If there was any, they would certainly be bragging about it.

Oh, and how many years of approvals, tons of cost, and clinical trials will it take for this psilocybin pipe dream to ever come true? We heard the same broken promises concerning Cannastrips for years, and we know how that ended.

How's those Cannastrips sales going?
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities